Powered By Blogger

Monday 18 April 2011

jesus nail found

Two nails that Israeli journalist Simcha Jacobovici says may have been used in the crucifixion of Jesus Christ are shown during a press conference on April 12, 2011, in Jerusalem. The Israel Antiquities Authority, however, cast doubt on Jacobovici's claims
Lior Mizrahi / Getty Images
Just in time for Easter, an Israeli television journalist has produced a pair of nails he says may have been used to crucify Jesus Christ. "We're not saying these are the nails," says Simcha Jacobovici, holding aloft a pair of smallish iron spikes with the tips hammered to one side. "We're saying these could be the nails."
The case for the possible rests on a specific combination of research, surmising, guesswork and either the ineptitude or the skittishness of Israeli archeologists who inventoried the tomb thought to contain the bones of the Jewish high priest who ordered Christ's arrest. The tomb, found in 1990, appeared to contain the ossuary, or bone box, of Caiaphas, the jurist who paved the way for the crucifixion. Researchers from the Israel Antiquities Authority (IAA) listed everything found in the cave, including two Roman nails. But unlike everything else in the grave, the nails were otherwise unaccounted for. They were not measured, sketched or photographed, and nowhere to be found in the IAA's vast collection. (See the top 10 Jesus films.)
At about the same time, a pair of nails showed up at the Tel Aviv University laboratory of Professor Israel Hershkowitz, a forensic expert. His lab already had the only known nail unassailably used in a crucifixion — it was found still embedded in the human heel bone it had been driven through. The mystery nails were smaller but similar: clearly ancient and with the tips hammered sideways, probably to secure them to the surface they've been pounded through. In The Nails of the Cross, the documentary Jacobovici made for Israeli TV and the History Channel, Hershkowitz says the two appear long enough to have been driven through a hand, but that's as far as he'll go. (See "Are the Bible's Stories True? Archaeology's Evidence."
The producer doesn't blame him. "When you raise the question of Jesus' crucifixion nails," Jacobovici says, "there should be a lot of skepticism."
Indeed the case arrives with no shortage of loose ends. The IAA's inventory states that one nail was found on the floor of the tomb, or cave, and another was found inside an ossuary. But there were 12 ossuaries in the tomb, and there is no record of which one it was in.
Nor is it clear which box most likely contained the bones of the priest the Gospels say pushed Jesus toward death. Caiaphas is an unusual name, not found in any of the other 2,000 ossuaries recovered so far around Jerusalem from roughly the time of Christ. But in this tomb, the name shows up twice. Scholars have focused on an ornate box labeled "Joseph, son of Caiaphas," but Jacobovici suggests the priest's bones were gathered in a simpler one labeled only "Caiaphas." (See the top 10 Vatican pop-culture moments.)
Also unclear: Why would a priest be buried with a nail? Jacobovici points to scholarship indicating crucifixion nails were regarded by contemporary Jews as holding special healing powers. The bit of paganism was apparently tolerated, even in priestly circles: a woman's skull found in the same tomb contained a Roman coin, presumably included to pay the boatman steering souls across the River Styx.
Gaby Barkay, a professor at Bar Ilan University and probably the most prominent archeologist in Israel, offers another explanation. Jews at the time of Christ "were impurity freaks," Barkay says. Anything in the vicinity of a corpse was thought to be contaminated by death, even a nail stuck in a nearby wall. "Therefore it would probably be removed and put into the grave," he says.
The professor quibbles with other assumptions as well, but notes that "nails in general are a rare thing in tombs of the Second Temple Period," and his presence at a crowded news conference has added weight to Jacobovici's effort. The documentary's producer has won three Emmys and an Overseas Press Club Award, and clearly has earned the respect of scholars willing to tolerate a bit of show business in the bargain. As Barkay puts it, "This is not the way to draw conclusions in science, but it is nonetheless interesting." (See the top 10 religious relics.)
Most interesting of all, perhaps, is that 20 years passed before anyone brought attention to the nails in the tomb of the man history knows only for his key role in Christ's crucifixion. The implication, never stated quite out loud in the documentary, is that Jewish archeologists in charge of the dig had little stomach for drawing attention to the Jewish official the Gospels cast as the main villain in the Passion play. Jacobovici notes that Caiaphas may be the only figure named in the Bible whose tomb most scholars agree has been discovered, and the producer spends half the documentary trying to locate it and get a peek inside. The site, uncovered during construction of a park, ends up beneath a stretch of road near a playground.
"Two thousand years of anti-Semitism has been built on this man," says Jacobovici, who promotes an alternative view of the priest. The Nails of the Cross dwells on 1st century non-Gospel writings that portray Caiaphas as an eventual follower of Christ. It's a view that not only softens tensions between Christianity and Judaism, but also offers a possible reason for the presence of the nails in the family tomb: veneration. "I don't think anybody's going to say, 'Crucifixion Nails' exclamation point," Jacobovici says. "I think they're going to write, 'Crucifixion Nails' question mark."
Both headlines summon associations with pieces of the "one true cross" peddled to holy pilgrims at least since Emperor Constantine's mother journeyed to Jerusalem 300 years after the event — and claimed to find it. But at least, the producer tells TIME, the suggestion rises at least in part from the archeological record. "Entire churches have been built around nails that have a lot less going for them than these do," he says.
Watch "Archaeology Digs Up Controversy in Jerusalem."
See pictures of 60 years of Israel.

Hooked on Addiction: From Food to Drugs to Internet Porn

America is having an addiction moment. Media headlines scream daily about new neuroscience findings on porn addiction, Internet addiction, food addiction and plain, old-fashioned drug addiction. As TIME's Michael Scherer wrote last week, 42 U.S. Senators called on Attorney General Eric Holder to increase obscenity prosecutions for pornography, due in part to fears over sex addiction. There's even a new online magazine about addiction called The Fix (full disclosure: I write for it).
But what do the recent neuroscience studies actually tell us about addiction? What is addiction really? An article on the website referenced by the U.S. Senators in their letter to Holder explained sex addiction this way:
Cocaine, opioids, alcohol, and other drugs subvert, or hijack, the brain's pleasure systems, and cause the brain to think a drug high is necessary to survive. Evidence is now strong that natural rewards such as food and sex affect the reward systems in the same way drugs affect them, thus the current interest in 'natural addiction.' Addiction, whether to cocaine, food, or sex occurs when these activities cease to contribute to a state of homeostasis, and instead cause adverse consequences.
But this is actually a bizarre form of circular reasoning. For one thing, it confuses the original purpose of the brain's pleasure pathways. If you think about it, these regions aren't very likely to have evolved specifically to enable us to get high on cocaine or heroin - that would be evolutionary sabotage. But they almost certainly did evolve to get us to pursue food and sex relentlessly, in order to guarantee our survival. So, these brain regions are designed to make food and sex fun. (More on TIME.com: Addiction Files: Recovering From Drug Addiction, Without Abstinence) Suggesting that drugs "hijack" these reward systems to produce addiction implies that under normal circumstances - in the pursuit of "healthy" urges like eating and sex - these systems wouldn't cause addiction. Except of course the same reasoning, turned around, is used to argue that in fact food and sex are addictions - because they activate the brain regions that generate pleasure from drugs.
All that can actually be said based on this data is that food, sex, drugs - and anything else that's fun - activate brain regions and cause pleasure, and that people enjoy and pursue pleasure. However, that does little to explain why said brain activity can sometimes cause addiction, but mostly doesn't. The vast majority of people aren't food or drug addicts - and it's not clear what's different about the minority who are. (More on TIME.com: Does Men's 'Bond' with Porn Ruin Them for Real-Life Sex?)
So pleasure alone isn't addiction - and not even craving plus pleasure are enough to define addiction. The most accepted definition, as implied by the link above, describes addiction as compulsive behavior related to a substance or activity that people continue to engage in despite negative consequences. That's the essence of the definition used by the DSM, psychiatry's diagnostic manual.
It's a complex phenomenon that goes beyond mere activation of pleasure pathways. Unfortunately, most animal and brain-imaging studies tell us very little about it. Last week, for example, I reported on a study about "food addiction": researchers found that when women were presented with a chocolate milkshake, those who had more symptoms of food addiction had greater activity in brain regions linked with pleasure and craving, and reduced activity in areas connected with self-control, compared with those who had few or no food-addiction symptoms.
That's interesting, but again all it really shows is that symptomatic participants predictably reported more pleasure and craving, and less self-control. And it's important to note that none of the women in the study actually had food addiction; some had symptoms, but none had full-fledged eating disorders. The brain differences shown in the study, therefore, were seen in perfectly normal people - most of whom, prior research suggests, will never be addicted to food. (More on TIME.com: Heroin Versus Häagen-Dazs: Food Addiction and the Brain)
No study has ever isolated a simple brain change that is always seen in addicts and never in non-addicts. And although some studies have found changes that can help predict an addict's odds of relapse, they're not always accurate.
This failure to define or understand the blurry line between the normal and the pathological leads to all kinds of misconceptions about addiction: for example, thinking that simple exposure to a substance or experience is enough to create addiction. Most of us enjoy the occasional chocolate milkshake, but virtually none of us would rob a bank to get one if the price became unaffordable. Similarly, more than 97% of people who take opioid painkillers like Oxycontin as prescribed, and don't have a prior history of addiction, do not become addicted, studies show. (More on TIME.com: Why French Fries Are Such Good Comfort Food)
And as Virginia Heffernan pointed out in the New York Times this week, college students who define themselves as "Internet addicts" don't actually behave very differently than their predecessors who were also occasionally known to blow off homework and stay up late in pursuit of a hobby or interest.
Addiction research is continually filling in parts of the puzzle of addictive behavior. But to use existing evidence to claim that sex and food create overpowering drives by "hijacking" the brain's pleasure pathways doesn't tell the whole story. We need to understand a lot more about how we control and choose our behavior ordinarily before we can truly know what causes our decisions to go awry in addiction. If we don't understand how food and sex normally affect our brains and our choices, how can we understand what triggers addictions to any substance or experience?

Gang members indicted in online prostitution ring

SAN DIEGO (Reuters) – Three dozen Crips street gang members and two motel owners have been indicted for running a prostitution ring that targeted underage girls through social networking sites including MySpace, Craigslist, Twitter and Facebook, prosecutors said on Monday.
The U.S. District Court indictment, unsealed on Monday, alleges that several former rival factions of the gang worked together to recruit new prostitutes by targeting underage girls from broken homes.
Writing letters from prison as well as establishing contact using MySpace, Twitter and Facebook, the gang members gained control over the girls and then advertised them using Craigslist and Backpage.com, as well as more traditional methods, according to the indictment.
Adult women were also recruited, abused and traded among pimps, the indictment alleges.
"I regard the kind of prostitution involved in this case, including the trafficking of children via the Internet, social networking sites and local businesses, as a form of modern-day slavery to which every available law enforcement resource will be applied," Laura Duffy, U.S. Attorney for the Southern District of California, said at a press conference to announce the indictments.
Duffy said investigators had rescued about 30 underage girls from the pimps, who took them on the road to Arizona, Nevada, Colorado, Florida, Texas and Michigan and forced them to work.
The indictment also charges Vinod Patel, 60, and Hitesh Patel, 27, with being part of the conspiracy by providing a rooms at the Oceanside Travelodge motel, knowing they were being used for illegal activity.
According to the indictment, the rooms were isolated from the legitimate business clients and were sold to the gang members at a higher cost than the legitimate lodgers.
Prosecutors said the 38 defendants face up to 20 years in prison and a maximum fine of $250,000.
The government is also seeking the forfeiture of the motel.

Pope's shrink film stirs controversy in Italy

VATICAN CITY (AFP) – A new film about a panic-prone pope who needs a psychoanalyst has divided Italy's Catholics, with a call for its boycott coming from the pages of an influential bishops' newspaper.
Writing in the Avvenire daily, Vatican expert Salvatore Izzo said Italian director Nanni Moretti's film "Habemus Papam" was not respectful towards the head of the world's Roman Catholics and would be "boring" for non-believers.
"We shouldn't touch the pope -- the rock on which Jesus founded his Church," said Izzo, adding that "even priests" had absolved the film after its release on Friday "with the curious justification that Moretti could have been meaner."
"Why should we support financially that which offends our religion?" said Izzo, who writes about the Vatican for Italian news agency AGI.
The film comes just ahead of Easter, on Sunday, and the beatification ceremony in the Vatican on May 1 that will put late pope John Paul II on the path to sainthood.
The film starring 85-year-old French actor Michel Piccoli as the man who is reluctant to become pope is being shown in 447 cinemas and grossed 1.3 million euros (1.9 million dollars) over the weekend -- receiving mostly positive reviews.
Jesuit journal Civilta Cattolica praised the film and Vatican Radio said that it contained "no irony, no caricature" of the pope.
Izzo's editorial does not mean the Italian bishops' paper shares his views and some observers are hoping the controversy does not go any further.
"It would be embarrassing.... This film is respectful. It has to be taken as the light comedy that it is," Vatican expert Luigi Accattoli told AFP.
Sandro Magister, another Vatican expert, said there are divisions over the film but no official condemnation from Church authorities.
"If there was to be one, it would only help the producer. He would be very happy with a polemic that is completely without foundation," he said.
It is unlikely that any boycott will go far, as previous such initiatives by the Church have tended to have a boomerang effect.
Heavy criticism from senior Catholic clergy of the "Da Vinci Code" by Ron Howard in 2006 helped turn it into a blockbuster.
Asked about the controversy in an interview for RAI3 television, Moretti said: "There is freedom of expression in my work. I am not commenting." The director then quipped: "People can boycott it after seeing it!"
Many commentators have hailed a film that touches a sensitive point.
Pope Benedict XVI said his election to the papacy in 2005 felt like "a guillotine" and the late pope John Paul I, who died just 33 days after being elected in 1978, told his advisers he did not want to accept the heavy burden.
But in the end they both could not say no to a charge that the faithful believe is divinely-inspired -- unlike the pope in the film who resigns his duties.
The head of the Catholic Association of Cinema Workers, Roberto Busti, criticised "Moretti's willingness to introduce psychoanalysis in the Vatican."
He deplored the film for showing "faith cannot remedy natural weaknesses."
"The story does not talk about faith," Busti said.

help

FILE- In this May 29, 2006 file photo, HIV-positive ... 
         THEY ARE DYING, TRY SAVE A SOUL VIA YOUR DONATION IN http://www.redcrosssociety.com..... WHATEVER YOU GIVE CAN COUNT!!!!!!!

AIDS prevention pill study halted; no benefit seen

AIDS prevention pill study halted; no benefit seen

Researchers are stopping a study that tests a daily pill to prevent infection with the AIDS virus in thousands of African women because partial results show no signs that the drug is doing any good.
Women taking Truvada (true-VAH'-duh), made by Gilead Sciences Inc., are just as likely to get HIV as other women who have been given dummy pills, an interim analysis of the study found. Even if the study were to continue, it would not be able to determine whether the pills help prevent infection, since the results are even this far along, researchers said.
The finding is disappointing because another study last fall concluded that Truvada did help prevent infections in gay and bisexual men when given with condoms, counseling and other prevention services. Many AIDS experts view that as a breakthrough that might help slow the epidemic.
Family Health International, a nonprofit involved in AIDS research, announced the new results on Monday. The group launched the study two years ago and had enrolled about half of the 3,900 women intended in Kenya, Tanzania and South Africa. As of last week, 56 new HIV infections had occurred, half in each group.
No safety problems were seen with Truvada. However, women taking it were more likely to become pregnant than those on dummy pills.
"That's both a surprising finding and one that we can't readily explain" by what is known so far about Truvada's effects on women using hormonal contraceptives, said Dr. Timothy Mastro of Family Health International. The study was sponsored by the U.S. Agency for International Development and the Bill & Melinda Gates Foundation. Gilead provided the drugs for the study.
Truvada already is sold for treating HIV. It's a combination of two drugs, tenofovir and emtricitabine, or FTC, made by California-based Gilead Sciences Inc.
Using it or its components for prevention is still "very promising," Mastro said, although benefits and risks may vary by gender and by the way the virus is spread — sex between men and women or riskier anal sex among men, for example.
Last year, a study in South Africa found that a vaginal gel spiked with tenofovir cut in half a woman's chances of getting HIV from an infected partner. Protection was greater for those who used it most faithfully.
A similar effect was seen in the study of Truvada in gay men. The drug lowered the chances of infection by 44 percent, and by 73 percent or more among men who took their pills most faithfully. The U.S. Centers for Disease Control and Prevention recently gave advice to doctors on prescribing Truvada along with other prevention services for gay men, based on those encouraging results.
In the new study, "it's difficult to understand why they did not see protection," but blood samples may tell more about whether it's related to how faithfully women took the pills, said Dr. Robert M. Grant of the Gladstone Institutes, a private foundation affiliated with the University of California, San Francisco.
He led the study of Truvada in gay men and said, "we are very confident that this approach is useful" for them.
The new study's result "must be seen as what it is — the closure of a single trial in a field that has generated exciting results in the recent past," said Mitchell Warren, head of the AIDS Vaccine Advocacy Coalition, a nonprofit group that works on HIV prevention research.
Two other large studies testing AIDS drugs for prevention are under way in Africa, in heterosexual women and in couples where one has the virus and the other does not. Results are expected within two years. The studies have mostly been in countries with high rates of new infections because that makes it easier to see whether a prevention measure is having an impact.
Truvada costs $5,000 to $14,000 a year in the United States, but as little as $140 a year in some poor countries where it's available in generic form.
___
Online:
CDC: http://www.cdc.gov/hiv/prep/resources/qa/index.htm
AIDS information: www.aidsinfo.nih.gov

Starting HIV Drugs Earlier May Delay AIDS But Not Death

MONDAY, April 18 (HealthDay News) -- New research suggests that HIV-infected patients are most likely to stay clear of AIDS longer if they start drug therapy when their immune systems are still relatively strong.
However, starting treatment earlier, compared to waiting, didn't affect dying from AIDS.
"There wasn't a clear benefit in terms of preventing death" by prescribing the drugs before some guidelines suggest, said Dr. Keith Henry, director of HIV clinical research at Hennepin County Medical Center in Minneapolis and co-author of a commentary accompanying the study, published in the April 19 edition of Annals of Internal Medicine.
The issue of when to begin drug treatment is a hot topic in the field of AIDS/HIV medicine. If physicians wait to begin treatment, patients can delay the expense -- not to mention the side effects -- of pricey anti-HIV drugs. But such delays may also give the virus a chance to become more powerful and better able to fend off medications.
If they're not treated with drugs, HIV-infected people almost always go on to develop AIDS.
So when should doctors turn to the drugs? In the U.S., guidelines suggest that HIV-infected patients take them when the level of CD4 cells -- an important part of the immune system -- dips below 0.500 X 109 cells per liter (cells/L). In Europe, the guideline number is frequently lower -- meaning a weaker immune system -- at under 0.350 X 109 cells/L.
In the new study, researchers examined how patients did when they began drug therapy with their CD4 cells at a variety of levels.
The study authors examined the medical records of almost 21,000 HIV-infected patients who sought treatment in HIV clinics in Europe and through the Veterans Health Administration system in the United States. The researchers found that the death rate was about the same regardless of whether patients began treatment when their CD4 levels dipped under 0.500 X 109 cells/L or if they waited until their immune systems deteriorated more and reached below the level of 0.350 X 109 cells/L.
However, the risk of death did rise when patients weren't treated until their CD4 cells fell to an even lower level: 0.200 X 109 cells/L.
Patients were better able to stave off AIDS itself when they began treatment when their immune systems were stronger -- when they dipped below 0.500 X 109 cells/L.
In other words, starting treatment early -- when levels dip below 0.500 X 109 cells/L -- didn't seem to help patients live longer compared to starting it a bit later. But it did appear to keep AIDS from developing as quickly.
What to do?
"To fully benefit from early initiation, patients must present for medical care while their CD4 cell counts are still above 500 cells," said study lead author Lauren Cain, a research fellow at Harvard School of Public Health.
There are other issues to consider, added Henry, the commentary co-author. When it comes to available money for HIV/AIDS treatment, "the U.S. is actually a resource-poor country," Henry said, which makes it difficult to say that patients should always get the HIV drugs early. "You have to make some decisions about who you treat. In a perfect world maybe everybody should be treated. But guess what? It's not a perfect world," he added.
And in far too many cases, he said, "the decision is already made" -- patients don't go to get treated until it's too late to begin early therapy, anyway. That's because the levels of immune cells in their bodies have already dwindled too far.